Meeting Banner
Abstract #0235

Sustained Restoration of LV Dysfunction in a Pig Ischemia-Reperfusion Injury Model Using Human Amnion-Derived Mesenchymal Stem Cells Tracked by Manganese-Enhanced MRI

Rajesh Dash1, Paul Kim1, Yuka Matsuura1, Fumiaki Ikeno1, Jennifer Lyons1, Xiaohu Ge1, Scott Metzler2, Ngan Huang1, Patricia Nguyen3, Joseph Wu1, 4, John Cooke1, Pilar Ruiz-Lozano2, Robert C. Robbins5, Michael V. McConnell1, Alan C. Yeung1, Phillip Harnish6, Phillip C. Yang1

1Medicine / Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA, United States; 2Pediatrics, Lucille Packard Childrens Hospital, Stanford, CA, United States; 3Medicine / Cardiovascular Medicine, Palo Alto VA Medical Center, Stanford, CA, United States; 4Radiology, Stanford University Medical Center, Stanford, CA, United States; 5Cardiac Surgery, Stanford University Medical Center, Stanford, CA, United States; 6Eagle Vision Pharmaceutical Corporation, Downington, PA, United States

We delivered human amnion-derived mesenchymal stem cells (hAMSCs) intramyocardially and tracked in vivo survival using manganese-enhanced MRI (MEMRI). hAMSC therapy led to durable improvements cardiac function due to prolonged survival in vivo, which was confirmed by both MEMRI and co-localized signal from a HSV-tk PET reporter gene. Significant, persistent increases in ejection fraction, as well as reduced LV dilatation and scar volume were observed for up to 6 weeks after hAMSC therapy. Notably, MEMRI CNR increased over time in hAMSC-treated hearts, and immunohistochemistry confirmed the presence of hAMSCs with both human anti-mitochondrial and anti-nuclear antigen antibody staining.

Abstract PDF Presentation Video

Keywords

agent allows amnion anterior anti antibody apical arrows assess assessment audience axis blue border calcium cardiac cardiovascular catheter cell cells cellular channels chronic clinician clusters confirmation confirmed contrast control controls coronary dash days decreased defect delayed delineates delivery derived descending directly disease dysfunction eagle either ejection enhanced enhancement evidenced excite exhibit exhibited exhibiting farm fraction function gadolinium gain gene genetic gross heart hearts hospital human hypothesis improved improvement in vivo increasing indicating indicative infarct injected injection injured injury investigate john live localizing loss manganese markers mass mechanism medical medicine million minimal model models molecular moreover myocardial noise nuclear pediatrics periods pharmaceuticals pigs populations porcine post promote quantification radiology reduction reporter restoration revealed saline salvage scientists section segments short significantly specifically stain stem suggesting support surface surgery survival survive sustained swine systolic target therapy tracked transplantation transplanted triangles type unclear underwent upon ventricular viability viable vision volume weekly whereas whether white yellow zone zones